These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18418319)

  • 21. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
    Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
    Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between neuromuscular diseases and cancers].
    Takamori M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1841-51. PubMed ID: 10581772
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose rituximab and anti-MAG-associated polyneuropathy.
    Renaud S; Fuhr P; Gregor M; Schweikert K; Lorenz D; Daniels C; Deuschl G; Gratwohl A; Steck AJ
    Neurology; 2006 Mar; 66(5):742-4. PubMed ID: 16534115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-associated polyneuropathy syndromes: principles and treatment.
    Kornberg AJ; Pestronk A
    Semin Neurol; 2003 Jun; 23(2):181-90. PubMed ID: 12894383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
    Maddison P; Newsom-Davis J; Mills KR; Souhami RL
    Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
    [No Abstract]   [Full Text] [Related]  

  • 26. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
    Lipka AF; Verschuuren JJ; Titulaer MJ
    Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lambert-Eaton myasthenic syndrome and polyneuropathy in a patient with epidermoid carcinoma of the lung.
    Comola M; Nemni R; Sher E; Quattrini A; Faravelli A; Comi G; Corbo M; Clementi F; Canal N
    Eur Neurol; 1993; 33(2):121-5. PubMed ID: 8385613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of Eaton-Lambert syndrome with a clinical recovery following surgical removal of the tumor].
    Shimada T; Joichi T; Murai S; Miyajima M; Shimojo S; Miyahara T
    Nihon Naika Gakkai Zasshi; 1987 May; 76(5):707-12. PubMed ID: 2855337
    [No Abstract]   [Full Text] [Related]  

  • 29. Eaton-Lambert syndrome.
    N Y State J Med; 1991 Jan; 91(1):8-14. PubMed ID: 1847235
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term effect of rituximab in anti-mag polyneuropathy.
    Benedetti L; Briani C; Franciotta D; Carpo M; Padua L; Zara G; Zambello R; Sormani MP; Mancardi GL; Nobile-Orazio E; Schenone A
    Neurology; 2008 Nov; 71(21):1742-4. PubMed ID: 19015493
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lambert-Eaton myasthenic syndrome. Physiopathological aspects and therapeutic modalities].
    Kuntzer T; Steck AJ; Fiorini E; Mirimanoff RO; Regli F
    Rev Neurol (Paris); 1991; 147(12):819-24. PubMed ID: 1688363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 33. [Small cell lung cancer with Lambert-Eaton myasthenic syndrome].
    Tang XF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):17-9, 61. PubMed ID: 2553355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of small cell lung carcinoma complicated by Lambert-Eaton myasthenic syndrome].
    Isobe Z; Suga T; Katou T; Hara K; Aoki F; Aoyagi K; Ueno M; Maeno T; Kurabayashi M
    Nihon Kokyuki Gakkai Zasshi; 2008 Mar; 46(3):226-31. PubMed ID: 18409571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An unusual cause of dysphagia.
    Payne S; Wilkins D; Howard R
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):146. PubMed ID: 15608023
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lambert-Eaton myasthenic syndrome: response to treatment with 3,4-diaminopyridine].
    Morata C; Alfaro A; Chumillas MJ; Montalar J
    Med Clin (Barc); 1995 Feb; 104(4):156. PubMed ID: 7898163
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma.
    Willcox N; Demaine AG; Newsom-Davis J; Welsh KI; Robb SA; Spiro SG
    Hum Immunol; 1985 Sep; 14(1):29-36. PubMed ID: 2993207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
    Peterlin BL; Flood W; Kothari MJ
    J Am Osteopath Assoc; 2002 Dec; 102(12):682-4. PubMed ID: 12501987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two cases of Lambert-Eaton syndrome with an increase of serum cholinesterase activity].
    Ciechanowski K; Cebula D
    Pol Merkur Lekarski; 1997 Feb; 2(8):132-3. PubMed ID: 9538660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.